ERWINAZE is a Intramuscular; Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Asparaginase Erwinia Chrysanthemi.
| Product ID | 57902-249_4da45931-b925-4f47-9cf1-4fcfb12c5b29 |
| NDC | 57902-249 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ERWINAZE |
| Generic Name | Asparaginase |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2011-11-18 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125359 |
| Labeler Name | Jazz Pharmaceuticals, Inc. |
| Substance Name | ASPARAGINASE ERWINIA CHRYSANTHEMI |
| Active Ingredient Strength | 10000 [iU]/mL |
| Pharm Classes | Asparaginase [CS],Asparagine-specific Enzyme [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2011-11-18 |
| Marketing End Date | 2021-07-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-11-18 |
| Marketing Category | BLA |
| Application Number | BLA125359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-11-18 |
| Ingredient | Strength |
|---|---|
| ASPARAGINASE ERWINIA CHRYSANTHEMI | 10000 [iU]/mL |
| SPL SET ID: | 30bdf2ea-008b-4cbb-81e4-c3474f2ad286 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 57902-249 | ERWINAZE | Asparaginase |
| 81561-413 | ERWINASE | asparaginase |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ERWINAZE 90081574 not registered Live/Pending |
Porton Biopharma Limited 2020-07-29 |
![]() ERWINAZE 85245951 4147569 Live/Registered |
PORTON BIOPHARMA LIMITED 2011-02-18 |
![]() ERWINAZE 85031446 not registered Dead/Abandoned |
EUSA Pharma (Europe) Limited 2010-05-06 |